Author:
Tscharntke Lene T.,Jung Norma,Hanses Frank,Koll Carolin E. M.,Pilgram Lisa,Rieg Siegbert,Borgmann Stefan,de Miranda Susana M. Nunes,Scherer Margarete,Spinner Christoph D.,Rüthrich Maria,Vehreschild Maria J. G. T.,von Bergwelt-Baildon Michael,Wille Kai,Merle Uta,Hower Martin,Rothfuss Katja,Nadalin Silvio,Klinker Hartwig,Fürst Julia,Greiffendorf Ingo,Raichle Claudia,Friedrichs Anette,Rauschning Dominic,de With Katja,Eberwein Lukas,Riedel Christian,Milovanovic Milena,Worm Maximilian,Schultheis Beate,Schubert Jörg,Bota Marc,Beutel Gernot,Glück Thomas,Schmid Michael,Wintermantel Tobias,Peetz Helga,Steiner Stephan,Ribel Elena,Schäfer Harald,Vehreschild Jörg Janne,Stecher Melanie,
Abstract
Abstract
Purpose
This study investigates the care provision and the role of infectious disease (ID) specialists during the coronavirus disease-2019 (COVID-19) pandemic.
Methods
A survey was conducted at German study sites participating in the Lean European Open Survey on SARS-CoV-2 infected patients (LEOSS). Hospitals certified by the German Society of Infectious diseases (DGI) were identified as ID centers. We compared care provision and the involvement of ID specialists between ID and non-ID hospitals. Then we applied a multivariable regression model to analyse how clinical ID care influenced the mortality of COVID-19 patients in the LEOSS cohort.
Results
Of the 40 participating hospitals in the study, 35% (14/40) were identified as ID centers. Among those, clinical ID care structures were more commonly established, and ID specialists were always involved in pandemic management and the care of COVID-19 patients. Overall, 68% (27/40) of the hospitals involved ID specialists in the crisis management team, 78% (31/40) in normal inpatient care, and 80% (28/35) in intensive care. Multivariable analysis revealed that COVID-19 patients in ID centers had a lower mortality risk compared to those in non-ID centers (odds ratio: 0.61 (95% CI 0.40–0.93), p = 0.021).
Conclusion
ID specialists played a crucial role in pandemic management and inpatient care.
Funder
Universitätsklinikum Köln
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. World Health Organization (WHO). COVID-19 Public Health Emergency of International Concern (PHEIC) global research and innovation forum: towards a research roadmap.
2. Deutsches Netzwerk Versorgungsforschung e.V. (DNVF). Stellungnahme des Deutschen Netzwerk Versorgungsforschung vom 29.10.2021: Wir brauchen Verlaufsdaten für ein evidenzgeleitetes und gezieltes Pandemiemanagement. 2021.
3. Robert Koch Institut (RKI). COVID-19 (Coronavirus SARS-CoV-2). [cited 2020 08.11.2021]. Available from: https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/nCoV.html.
4. Ständiger Arbeitskreis der Kompetenz- und Behandlungszentren für Krankheiten durch hochpathogene Erreger (STAKOB). Hinweise zu Erkennung, Diagnostik und Therapie von Patienten mit COVID-19 (Stand 16.07.2021).
5. Kluge S, Janssens U, Welte T. S3-Leitlinie - Empfehlungen zur stationären Therapie von Patienten mit COVID-19, Version Oktober 2021. 2021.